Evidence map›Paper›PMID 32300103›Full record

ArticleCell death & disease2020

Correction: Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor.

Zhiwei Zhang, Duqing Jiang, Huan Yang, Zhou He, Xiangzhen Liu, Wenxia Qin, Linfang Li, Chao Wang, Yang Li, He Li and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Zhiwei Zhang *Department of Biotherapy, The Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, 201805, China.
Duqing Jiang *Shanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Huan Yang *Shanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Zhou He *Shanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Xiangzhen LiuShanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Wenxia QinShanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Linfang LiShanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Chao WangShanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Yang LiShanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
He LiDepartments of Respiratory and Critical Care Medicine, Changhai Hospital, Navy Medical University (Second Military Medical University), Shanghai, 200433, China.
Hai XuShanghai Engineering Research Center for Cell Therapy, Shanghai, 201805, China.
Huajun JinDepartment of Biotherapy, The Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, 201805, China. hj-jin@hotmail.com.
Qijun QianDepartment of Biotherapy, The Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, 201805, China. qian@shcell.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32300103
PMCPMC7162925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.